News

Written by Dr Jafar Jafari, GI Cognition This article reflects the opinions of a healthcare professional. The views expressed are their own. The intended use for the GastroCH4ECK® is to aid in the diagnosis of the following disorders: Lactose Intolerance,...

Shortlisting recognises Bedfont’s role in driving innovation and technology leadership across Kent. Scott Deamer-Smith, Chief Technology Officer (CTO) at Bedfont® Scientific Limited, has been recognised for his outstanding contribution to innovation and technology. Scott has spent an impressive 18 years...

Written by Melissa Dooley, GastroLife This article reflects the opinions of a healthcare professional. The views expressed are their own. The intended use for the GastroCH4ECK® is to aid in the diagnosis of the following disorders: Lactose Intolerance, Small Intestinal...

A collective community effort helps breathe new life into a much-loved school space. Bedfont® Scientific Limited, a local med-tech business located in Harrietsham, was pleased to help create a tranquil woodland-themed library for children at Harrietsham Church of England Primary...

Bedfont® appoints Michael Bencak to strengthen its position and accelerate growth. Bedfont® Scientific Ltd., a world leader in breath analysis, has been designing and manufacturing medical breath analysis devices for almost 50 years and has seen significant growth over the...

The NObreath® FeNO device offers a clear pathway to more effective asthma care, reducing over-reliance on blue inhalers. Bedfont® Scientific Limited, an innovative med-tech company specialising in medical breath analysis devices, welcomes the new study at University Hospital Southampton exploring...